These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28778440)

  • 21. Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
    Sellebjerg F; Krakauer M; Limborg S; Hesse D; Lund H; Langkilde A; Søndergaard HB; Sørensen PS
    PLoS One; 2012; 7(6):e35927. PubMed ID: 22701554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memory and naive CD4+ lymphocytes in multiple sclerosis.
    Porrini AM; Gambi D; Malatesta G
    J Neurol; 1992 Oct; 239(8):437-40. PubMed ID: 1360022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognition of viral and self-antigens by T
    Paroni M; Maltese V; De Simone M; Ranzani V; Larghi P; Fenoglio C; Pietroboni AM; De Riz MA; Crosti MC; Maglie S; Moro M; Caprioli F; Rossi R; Rossetti G; Galimberti D; Pagani M; Scarpini E; Abrignani S; Geginat J
    J Allergy Clin Immunol; 2017 Sep; 140(3):797-808. PubMed ID: 28237728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in naïve and memory T-cells in elite swimmers during a winter training season.
    Teixeira AM; Rama L; Carvalho HM; Borges G; Carvalheiro T; Gleeson M; Alves F; Trindade H; Paiva A
    Brain Behav Immun; 2014 Jul; 39():186-93. PubMed ID: 24412212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natalizumab differentially affects plasmablasts and B cells in multiple sclerosis.
    Cuculiza Henriksen A; Ammitzbøll C; Petersen ER; McWilliam O; Sellebjerg F; von Essen MR; Romme Christensen J
    Mult Scler Relat Disord; 2021 Jul; 52():102987. PubMed ID: 33984651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
    Sellebjerg F; Hesse D; Limborg S; Lund H; Søndergaard HB; Krakauer M; Sørensen PS
    Mult Scler; 2013 Feb; 19(2):179-87. PubMed ID: 22653658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The activation of memory CD4(+) T cells and CD8(+) T cells in patients with multiple sclerosis.
    Okuda Y; Okuda M; Apatoff BR; Posnett DN
    J Neurol Sci; 2005 Aug; 235(1-2):11-7. PubMed ID: 15972217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease in memory (CDw29-high) cerebrospinal fluid cells from acute MS patients.
    Marrosu MG
    Acta Neurol Scand; 1991 Dec; 84(6):487-90. PubMed ID: 1724333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
    Iannetta M; Zingaropoli MA; Bellizzi A; Morreale M; Pontecorvo S; D'Abramo A; Oliva A; Anzivino E; Lo Menzo S; D'Agostino C; Mastroianni CM; Millefiorini E; Pietropaolo V; Francia A; Vullo V; Ciardi MR
    PLoS One; 2016; 11(8):e0160277. PubMed ID: 27486658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.
    Harrer A; Pilz G; Wipfler P; Oppermann K; Sellner J; Hitzl W; Haschke-Becher E; Afazel S; Rispens T; van der Kleij D; Trinka E; Kraus J
    Clin Exp Immunol; 2015 Jun; 180(3):383-92. PubMed ID: 25603898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased CD8+ central memory T cells in patients with multiple sclerosis.
    Liu GZ; Fang LB; Hjelmström P; Gao XG
    Mult Scler; 2007 Mar; 13(2):149-55. PubMed ID: 17439879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab.
    Koudriavtseva T; Sbardella E; Trento E; Bordignon V; D'Agosto G; Cordiali-Fei P
    Clin Exp Immunol; 2014 Jun; 176(3):320-6. PubMed ID: 24387139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia.
    Moeini Shad T; Yousefi B; Amirifar P; Delavari S; Rae W; Kokhaei P; Abolhassani H; Aghamohammadi A; Yazdani R
    J Clin Immunol; 2021 Jan; 41(1):76-88. PubMed ID: 33052516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
    Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
    Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low Memory T Cells Blood Counts and High Naïve Regulatory T Cells Percentage at Relapsing Remitting Multiple Sclerosis Diagnosis.
    Canto-Gomes J; Silva CS; Rb-Silva R; Boleixa D; da Silva AM; Cheynier R; Costa P; González-Suárez I; Correia-Neves M; Cerqueira JJ; Nobrega C
    Front Immunol; 2022; 13():901165. PubMed ID: 35711452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple Sclerosis.
    Clottu AS; Mathias A; Sailer AW; Schluep M; Seebach JD; Du Pasquier R; Pot C
    Cell Rep; 2017 Jan; 18(1):213-224. PubMed ID: 28052250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis.
    Mikulkova Z; Praksova P; Stourac P; Bednarik J; Strajtova L; Pacasova R; Belobradkova J; Dite P; Michalek J
    Cell Immunol; 2010; 262(2):75-9. PubMed ID: 20219185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis.
    Krakauer M; Sorensen PS; Sellebjerg F
    J Neuroimmunol; 2006 Dec; 181(1-2):157-64. PubMed ID: 17081623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased proliferation within T lymphocyte subsets of HIV-infected adolescents.
    Starr SE; Sarr M; Campbell DE; Wilson CM; Douglas SD
    AIDS Res Hum Retroviruses; 2002 Nov; 18(17):1301-10. PubMed ID: 12487818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood non-MAIT CD8+CD161hi cells are decreased in relapsing-remitting multiple sclerosis patients treated with interferon beta.
    Negrotto L; Cantó E; Río J; Tintoré M; Montalban X; Comabella M
    J Neuroimmunol; 2015 Nov; 288():98-101. PubMed ID: 26531701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.